Literature DB >> 283399

Globin mRNAs are primers for the transcription of influenza viral RNA in vitro.

M Bouloy, S J Plotch, R M Krug.   

Abstract

Because influenza viral RNA transcription in vitro is greatly enhanced by the addition of a primer dinucleotide, ApG or GpG, we have proposed that viral RNA transcription in vivo requires initiation by primer RNAs synthesized by the host cell, specifically by RNA polymerase II, thereby explaining the alpha-amanitin sensitivity of viral RNA transcription in vivo. Here, we identify such primer RNAs, initially in reticulocyte extracts, where they are shown to be globin mRNAs. Purified globin mRNAs very effectively stimulated viral RNA transcription in vitro, and the resulting transcripts directed the synthesis of all the nonglycosylated virus-specific proteins in micrococcal nuclease-treated L cell extracts. The viral RNA transcripts synthesized in vitro primed by ApG also directed the synthesis of the nonglycosylated virus-specific proteins, but the globin mRNA-primed transcripts were translated about 3 times more efficiently. The translation of the globin mRNA-primed, but not the ApG-primed, viral RNA transcripts was inhibited by 7-methylguanosine 5'-phosphate in the presence of S-adenosylhomocysteine, suggesting that the globin mRNA-primed transcripts contained a 5'-terminal methylated cap structure. We propose that this cap was transferred from the globin mRNA primer to the newly synthesized viral RNA transcripts, because no detectable de novo synthesis of a methylated cap occurred during globin mRNA-primed viral RNA transcription. Preliminary experiments indicate that other purified eukaryotic mRNAs also stimulate influenza viral RNA transcription in vitro.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 283399      PMCID: PMC336226          DOI: 10.1073/pnas.75.10.4886

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Nucleotide sequences at the 5'termini of rabbit alpha and beta globin mRNA.

Authors:  R E Lockhard; U L Rajbhandary
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

2.  Inhibition of HeLa cell messenger RNA translation by 7-methylguanosine 5'-monophosphate.

Authors:  L A Weber; E R Feman; E D Hickey; M C Williams; C Baglioni
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

3.  Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

4.  Dependence on potassium concentration of the inhibition of the translation of messenger ribonucleic acid by 7-methylguanosine 5'-phosphate.

Authors:  B Kemper; L Stolarsky
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

5.  Participation of DNA-dependent RNA polymerase II in replication of influenza viruses.

Authors:  L L Spooner; R D Barry
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

6.  Cell-free coupling of influenza virus RNA transcription and translation.

Authors:  J Content; L D Wit; M Horisberger
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

7.  Segments of influenza virus complementary RNA synthesized in vitro.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

8.  Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts.

Authors:  J J Skehel; A J Hay
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

9.  Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

10.  Synthesis of influenza virus polypeptides in cells resistant to alpha-amanitin: evidence for the involvement of cellular RNA polymerase II in virus replication.

Authors:  R A Lamb; P W Choppin
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

View more
  116 in total

1.  Minimum molecular architectures for transcription and replication of the influenza virus.

Authors:  Ayae Honda; Kiyohisa Mizumoto; Akira Ishihama
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

2.  Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching.

Authors:  Erdong Cheng; Mohammad A Mir
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

Review 3.  Uncovering the mysteries of hantavirus infections.

Authors:  Antti Vaheri; Tomas Strandin; Jussi Hepojoki; Tarja Sironen; Heikki Henttonen; Satu Mäkelä; Jukka Mustonen
Journal:  Nat Rev Microbiol       Date:  2013-08       Impact factor: 60.633

4.  Sequence in the influenza A virus nucleoprotein required for viral polymerase binding and RNA synthesis.

Authors:  Jesper K Marklund; Qiaozhen Ye; Jinhui Dong; Yizhi Jane Tao; Robert M Krug
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II.

Authors:  A Rodriguez; A Pérez-González; A Nieto
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

6.  Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.

Authors:  P Vialat; M Bouloy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase.

Authors:  Erin Noble; Andrew Cox; Jerome Deval; Baek Kim
Journal:  Virology       Date:  2012-07-28       Impact factor: 3.616

8.  Characterization of La Crosse virus small-genome transcripts.

Authors:  J L Patterson; D Kolakofsky
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus.

Authors:  M M Lai; R S Baric; P R Brayton; S A Stohlman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity.

Authors:  M Hagen; T D Chung; J A Butcher; M Krystal
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.